• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

海兔毒素a通过阻止共翻译转运,可逆地抑制分泌途径。

Apratoxin a reversibly inhibits the secretory pathway by preventing cotranslational translocation.

作者信息

Liu Yanxia, Law Brian K, Luesch Hendrik

机构信息

Department of Medicinal Chemistry, University of Florida, Gainesville, FL 32610, USA.

出版信息

Mol Pharmacol. 2009 Jul;76(1):91-104. doi: 10.1124/mol.109.056085. Epub 2009 Apr 29.

DOI:10.1124/mol.109.056085
PMID:19403701
Abstract

Apratoxin A is a potent cytotoxic marine natural product that rapidly inhibits signal transducer and activator of transcription (STAT) 3 phosphorylation by an undefined mechanism. We have used biochemical and proteomics approaches to illuminate upstream molecular events. Apratoxin A inhibits Janus kinase (JAK)/STAT signaling through rapid down-regulation of interleukin 6 signal transducer (gp130). Apratoxin A also depletes cancer cells of several cancer-associated receptor tyrosine kinases by preventing their N-glycosylation, leading to their rapid proteasomal degradation. A proteomics approach revealed that several proteins in the endoplasmic reticulum, the site of N-glycoprotein synthesis, are down-regulated upon apratoxin A exposure. Using in vitro cell free systems, we demonstrated that apratoxin A prevents cotranslational translocation of proteins destined for the secretory pathway. This process is reversible in living cells. Our study indicates that apratoxins are new tools to study the secretory pathway and raises the possibility that inhibition of cotranslational translocation may be exploited for anticancer drug development.

摘要

阿普拉毒素A是一种强效的细胞毒性海洋天然产物,它能通过一种不明机制迅速抑制信号转导子和转录激活子(STAT)3的磷酸化。我们已采用生化和蛋白质组学方法来阐明上游分子事件。阿普拉毒素A通过快速下调白细胞介素6信号转导子(gp130)来抑制Janus激酶(JAK)/STAT信号通路。阿普拉毒素A还通过阻止几种癌症相关受体酪氨酸激酶的N-糖基化,使其从癌细胞中耗竭,导致它们迅速被蛋白酶体降解。蛋白质组学方法显示,N-糖蛋白合成位点内质网中的几种蛋白质在暴露于阿普拉毒素A后表达下调。利用体外无细胞系统,我们证明阿普拉毒素A可阻止分泌途径中蛋白质的共翻译转运。这一过程在活细胞中是可逆的。我们的研究表明,阿普拉毒素是研究分泌途径的新工具,并增加了一种可能性,即抑制共翻译转运可用于抗癌药物开发。

相似文献

1
Apratoxin a reversibly inhibits the secretory pathway by preventing cotranslational translocation.海兔毒素a通过阻止共翻译转运,可逆地抑制分泌途径。
Mol Pharmacol. 2009 Jul;76(1):91-104. doi: 10.1124/mol.109.056085. Epub 2009 Apr 29.
2
Apratoxin Kills Cells by Direct Blockade of the Sec61 Protein Translocation Channel.Apratoxin 通过直接阻断 Sec61 蛋白易位通道杀死细胞。
Cell Chem Biol. 2016 May 19;23(5):561-566. doi: 10.1016/j.chembiol.2016.04.008.
3
Inhibition of cotranslational translocation by apratoxin S4: Effects on oncogenic receptor tyrosine kinases and the fate of transmembrane proteins produced in the cytoplasm.Apratoxin S4对共翻译转运的抑制作用:对致癌受体酪氨酸激酶的影响以及细胞质中产生的跨膜蛋白的命运
Curr Res Pharmacol Drug Discov. 2021 Sep 8;2:100053. doi: 10.1016/j.crphar.2021.100053. eCollection 2021.
4
Improved total synthesis and biological evaluation of potent apratoxin S4 based anticancer agents with differential stability and further enhanced activity.改良的强效 apratoxin S4 型抗癌剂的全合成与生物评估,该抗癌剂具有不同的稳定性和进一步增强的活性。
J Med Chem. 2014 Apr 10;57(7):3011-29. doi: 10.1021/jm4019965. Epub 2014 Mar 24.
5
Capsaicin inhibits the IL-6/STAT3 pathway by depleting intracellular gp130 pools through endoplasmic reticulum stress.辣椒素通过内质网应激消耗细胞内gp130库来抑制IL-6/STAT3信号通路。
Biochem Biophys Res Commun. 2009 May 1;382(2):445-50. doi: 10.1016/j.bbrc.2009.03.046. Epub 2009 Mar 13.
6
Apratoxin A Shows Novel Pancreas-Targeting Activity through the Binding of Sec 61.海兔毒素A通过与Sec 61结合展现出新的胰腺靶向活性。
Mol Cancer Ther. 2016 Jun;15(6):1208-16. doi: 10.1158/1535-7163.MCT-15-0648. Epub 2016 Mar 29.
7
Apratoxin S10, a Dual Inhibitor of Angiogenesis and Cancer Cell Growth To Treat Highly Vascularized Tumors.阿普拉毒素S10,一种血管生成和癌细胞生长的双重抑制剂,用于治疗高度血管化肿瘤。
ACS Med Chem Lett. 2017 Sep 18;8(10):1007-1012. doi: 10.1021/acsmedchemlett.7b00192. eCollection 2017 Oct 12.
8
Development of apratoxin S10 (Apra S10) as an anti-pancreatic cancer agent and its preliminary evaluation in an orthotopic patient-derived xenograft (PDX) model.开发 apratoxin S10(Apra S10)作为一种抗胰腺癌药物,并在原位患者来源异种移植(PDX)模型中进行初步评估。
Invest New Drugs. 2019 Apr;37(2):364-374. doi: 10.1007/s10637-018-0647-0. Epub 2018 Aug 3.
9
SD-1029 inhibits signal transducer and activator of transcription 3 nuclear translocation.SD - 1029抑制信号转导子和转录激活子3的核转位。
Clin Cancer Res. 2006 Nov 15;12(22):6844-52. doi: 10.1158/1078-0432.CCR-06-1330.
10
Induction of gp130-related cytokines and activation of JAK2/STAT3 pathway in astrocytes precedes up-regulation of glial fibrillary acidic protein in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine model of neurodegeneration: key signaling pathway for astrogliosis in vivo?在1-甲基-4-苯基-1,2,3,6-四氢吡啶神经退行性变模型中,星形胶质细胞中gp130相关细胞因子的诱导和JAK2/STAT3信号通路的激活先于胶质纤维酸性蛋白的上调:这是体内星形胶质细胞增生的关键信号通路?
J Biol Chem. 2004 May 7;279(19):19936-47. doi: 10.1074/jbc.M309304200. Epub 2004 Mar 2.

引用本文的文献

1
Exploring the ER channel protein Sec61: recent advances in pathophysiological significance and novel pharmacological inhibitors.探索内质网通道蛋白Sec61:病理生理意义及新型药理学抑制剂的最新进展
Front Pharmacol. 2025 Jun 4;16:1580086. doi: 10.3389/fphar.2025.1580086. eCollection 2025.
2
Structural Modifications Reveal Dual Functions of the C-4 Carbonyl Group in the Fatty Acid Chain of Ipomoeassin F.结构修饰揭示了番薯酰胺F脂肪酸链中C-4羰基的双重功能。
Molecules. 2025 Jan 18;30(2):400. doi: 10.3390/molecules30020400.
3
Natural Cyclic Peptides: Synthetic Strategies and Biomedical Applications.
天然环肽:合成策略与生物医学应用。
Biomedicines. 2025 Jan 20;13(1):240. doi: 10.3390/biomedicines13010240.
4
Syntheses of Marine Natural Products via Matteson Homologations and Related Processes.通过马特森同系化反应及相关过程合成海洋天然产物
Mar Drugs. 2025 Jan 2;23(1):20. doi: 10.3390/md23010020.
5
Progress in the discovery and development of anticancer agents from marine cyanobacteria.从海洋蓝细菌中发现和开发抗癌药物的进展。
Nat Prod Rep. 2025 Feb 19;42(2):208-256. doi: 10.1039/d4np00019f.
6
Toward Understanding the Mechanism of Client-Selective Small Molecule Inhibitors of the Sec61 Translocon.深入了解Sec61转运体的客户选择性小分子抑制剂的作用机制
J Mol Recognit. 2025 Jan;38(1):e3108. doi: 10.1002/jmr.3108. Epub 2024 Oct 12.
7
Isolation, Structure Elucidation, and Biological Activity of the Selective TACR2 Antagonist Tumonolide and its Aldehyde from a Marine Cyanobacterium.从海洋蓝细菌中分离、结构鉴定和选择性 TACR2 拮抗剂 Tumonolide 及其醛的生物活性。
Chemistry. 2024 Sep 5;30(50):e202401393. doi: 10.1002/chem.202401393. Epub 2024 Jul 18.
8
Diastereomers of Coibamide A Show Altered Sec61 Client Selectivity and Ligand-Dependent Activity against Patient-Derived Glioma Stem-like Cells.柯巴酰胺A的非对映异构体对患者来源的胶质瘤干细胞样细胞表现出改变的Sec61底物选择性和配体依赖性活性。
ACS Pharmacol Transl Sci. 2024 May 14;7(6):1823-1838. doi: 10.1021/acsptsci.4c00049. eCollection 2024 Jun 14.
9
The Kavaratamides: Discovery of Linear Lipodepsipeptides from the Marine Cyanobacterium Using a Comparative Chemogeographic Analysis.Kavaratamides:利用比较化学生态地理分析从海洋蓝细菌中发现的线性脂肽。
J Nat Prod. 2024 Jun 28;87(6):1601-1610. doi: 10.1021/acs.jnatprod.4c00242. Epub 2024 Jun 4.
10
VCP/p97 mediates nuclear targeting of non-ER-imported prion protein to maintain proteostasis.VCP/p97 介导非内质网导入的朊病毒蛋白的核靶向以维持蛋白稳态。
Life Sci Alliance. 2024 Apr 3;7(6). doi: 10.26508/lsa.202302456. Print 2024 Jun.